Short Trade Idea
Enter your short position between $278.85 (an intermediate horizontal support level) and $285.87 (the lower band of its horizontal resistance zone).
Market Index Analysis
- Labcorp (LH) is a member of the S&P 500 Index.
- This index broke down below its horizontal resistance zone with rising bearish trading volumes.
- The Bull Bear Power Indicator of the S&P 500 Index is bearish with a descending trendline.
Market Sentiment Analysis
While Friday will dominate the economic calendar with the release of PCE and consumer confidence data, the AI-related selling pressure could persist this week. Software, real estate, financial services, and logistics stocks came under pressure amid uncertainty over how and to what extent AI will disrupt existing business models. US markets remain closed today due to Presidents’ Day, but this week will feature significant earnings releases from Walmart, DoorDash, Molson Coors, Constellation Energy, Energy Transfer, and Southern Company.
Labcorp Fundamental Analysis
Labcorp operates in over 100 countries, making it one of the largest clinical laboratory networks globally. Still, it derives most of its business from the US. Labcorp has over 70,000 employees, processes more than 160 million tests annually, and receives over 10% of its revenue from Medicaid.
So, why am I bearish on LH ahead of its earnings release?
I turned bearish on Labcorp due to weakening growth in its core segments, and the PAMA challenges that could wipe out as much as $100 million in annual revenues starting in 2026. While its FDA-cleared Alzheimer's blood test is encouraging, Labcorp downgraded its revenue outlook. Rising operational costs from tariffs on lab equipment, weakening demand, and increased competition from the likes of Quest Diagnostics, Roche, and Thermo Fisher, and investment in AI and personalized medicine are additional bearish factors. Therefore, I expect a subdued outlook with a revenue miss from its next earnings report.
Metric | Value | Verdict |
P/E Ratio | 27.71 | Bearish |
P/B Ratio | 2.69 | Bearish |
PEG Ratio | 2.07 | Bullish |
Current Ratio | 1.55 | Bearish |
ROIC-WACC Ratio | Negative | Bearish |
The price-to-earnings (P/E) ratio of 27.71 makes LH a reasonably priced stock. By comparison, the P/E ratio for the S&P 500 is 29.36.
The average analyst price target for LH is $300.18. It suggests limited upside potential with heightened downside risks.
Labcorp Technical Analysis
Today’s LH Signal
- The LH D1 chart shows price action breaking down below its horizontal resistance zone.
- It also shows price action between its ascending 0.0% and 38.2% Fibonacci Retracement Fan levels.
- The Bull Bear Power Indicator is bullish with a negative divergence.
- The average bearish trading volumes are higher than the average bullish trading volumes.
- LH advanced with the S&P 500 Index, a bullish confirmation, but bearish factors are accumulating.
My LH Short Stock Trade
- LH Entry Level: Between $278.85 and $285.87
- LH Take Profit: Between $245.00 and $250.89
- LH Stop Loss: Between $292.02 and $300.18
- Risk/Reward Ratio: 2.57
Ready to trade our analysis of Labcorp? Here is our list of the best stock brokers worth reviewing.